Henning Friis Andersen

Safety of Recombinant Activated Factor VII in Randomized Clinical Trials

Marcel Levi, Jerrold H. Levy, Henning Friis Andersen et al. · New England Journal of Medicine · 2010 · 678 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis

Sidney H. Kennedy, Henning Friis Andersen, Raymond W. Lam · Journal of Psychiatry and Neuroscience · 2006 · 218 citations

Pharmacy, Pharmacotherapy, Psychiatry +16

Escitalopram in the Treatment of Depressed Elderly Patients

Siegfried Kasper, Hans de Swart, Henning Friis Andersen · American Journal of Geriatric Psychiatry · 2005 · 100 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder

Ulla Lepola, Alan Wade, Henning Friis Andersen · International Clinical Psychopharmacology · 2004 · 93 citations

Medicine, Pharmacology, Pharmacotherapy +14

Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression

Per Bech, P. Tanghøj, Henning Friis Andersen et al. · Psychopharmacology · 2002 · 91 citations

Pharmacy, Pharmacology, Pharmacotherapy +17